Daiichi Sankyo Turkey

Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose to contribute to the enrichment of quality of life around the world. In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. With more than 120 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of...

Cardiovascular diseases,glucose metabolic disorders,infectious diseases,cancer / oncology,immunity and allergies,bones / joint diseases,and antibody drug conjugates and anticoagulation

Daiichi sankyo turkey operates in the Pharmaceutical manufacturing industry.

Daiichi sankyo turkey's revenue is $55.50m

Daiichi sankyo turkey has 51 - 200 employees.